IMMUNITYBIO

WIPO WIPO 2023

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke IMMUNITYBIO wurde als Wortmarke am 01.03.2023 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 18. Juli 2023

Markenform Wortmarke
Aktenzeichen 1739959
Länder Australien Kanada China Europäische Gemeinschaft Großbritannien Indien Japan Südkorea Mexiko
Basismarke US Nr. , 10. Juli 2024
Anmeldedatum 01. März 2023
Ablaufdatum 01. März 2033

Markeninhaber

9920 Jefferson Blvd.
Culver City CA 92032
US

Markenvertreter

3993 Howard Hughes Parkway, Suite 600 US

Waren und Dienstleistungen

05 Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; pharmaceutical preparations for low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, pharmaceutical preparations for cell therapies, monoclonal antibodies, cytokines, immune modulators, pharmaceutical preparations for low-dose chemotherapy and low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, pharmaceutical preparations for personalized neoepitope-based therapies and cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, and reagents
42 Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases
44 Medical services; medical information; providing medical information in the fields of immunotherapy via a website; providing medical information in the fields of human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases via a website; providing information relating to pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, infectious diseases, biologics, cells, and cell-derived preparations
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
01. März 2023 2023/26 Gaz US Eintragung

ID: 141739959